Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-10 |
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-10 |
mRNA | DAP3 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-09 |
mRNA | RAB13 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-07 |
mRNA | MTX1 | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-09 |
mRNA | GPATCH4 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-08 |
mRNA | SHC1 | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-08 |
mRNA | MRPL9 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |
mRNA | HAX1 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | PFDN2 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-08 |